Biolinq

Thanks Nasdaq for celebrating our recent $58M funding, as we advance our wearable biosensors for #metabolic health. ???? Press release: ?? https://lnkd.in/etnifyNB WSJ: ?? https://lnkd.in/eCWamfgr Drug Delivery Business: ?? https://lnkd.in/gt2gpYsc Medical Device Network: ?? https://lnkd.in/eUg9j-_X Longevity Technology: ?? https://lnkd.in/e_AUEke5 MassDevice: ?? https://lnkd.in/gt2gpYsc

Today, on World Diabetes Day, we can't ignore the global 800 million people and that's a 2022 stat. Impacting so many more individuals and families, pre-diabetics, Type 1 and Type 2, and co-morbidities. So proud of our Features Capital portfolio team at Biolinq that is working tirelessly to create impactful change through continuous monitoring, autonomous sensing and beyond. Rich Yang Jared Tangney Amy VandenBerg https://lnkd.in/eF2E-Q4W

Our CEO Rich Yang was speaking on #BioFuture panel: “The Next Frontier for Obesity Care: Opportunities and Obstacles Ahead for GLP-1s,” moderated by Sari Kaganoff, Chief Commercial Officer, Rock Health. The session discussed the obesity care landscape given the rise of GLP-1s and how their use may impact healthcare delivery and economics. The conversation also discussed anticipated changes to care paradigms, as well as potential future health and financial implications due to widespread use of GLP-1s. Panelists: * Dianna Budgeon, SVP, Clinical Operations, knownwell * Dan Knecht, MD MBA, Chief Clinical Innovation Officer, CVS Caremark * Sloan Saunders, CEO & Co-Founder, FlyteHealth * Adam Wolfberg, Chief Medical Officer, Virta Health Health * Rich Yang, CEO, Biolinq Thanks Demy-Colton for inviting us!

Conference season is in full swing—who else is heading to #BioFuture2024 next week? Join us on Tuesday, 10/29 as Rock Health Advisory’s Chief Commercial Officer, Sari Kaganoff, moderates “The Next Frontier of Obesity Care.” The session will delve into this rapidly evolving landscape, focusing on the rise of GLP-1s and their potential impact on healthcare delivery and economics. Expect to learn about anticipated changes to care paradigms, potential health and financial implications of widespread GLP-1 use, and how to navigate market disruptions to healthcare system impact and beyond. Joining Sari is an incredible group of experts from across the ecosystem:? ? Dianna Budgeon, SVP, Clinical Operations, knownwell ? Dan Knecht, MD MBA, Chief Clinical Innovation Officer, CVS Caremark ? Sloan Saunders, CEO & Co-Founder, FlyteHealth ? Adam Wolfberg, Chief Medical Officer, Virta Health ? Rich Yang, CEO, Biolinq If you're attending #BioFuture2024, we’d love to see you there! + for more on this topic, check out Rock Health Advisory’s insights on consumer perspectives of weight care: https://lnkd.in/ej23yeKA

Our CEO Rich Yang will be speaking on a panel at #BioFuture2024, Oct 28-30 in New York. We look forward to contributing to the discussion and exploring the latest topics shaping the future of #healthcare alongside industry leaders and trailblazing companies. Join us for insightful conversations driving the next wave of breakthrough innovation. Register at www.BioFuture.com! See you there.

?? #BioFuture2024 is coming to #NYC this month, from October 28-30! We're excited to highlight one of the featured panels, “The Next Frontier of Obesity Care: The Opportunities and Obstacles Ahead for GLP-1s.” Moderator Sari Kaganoff, Chief Commercial Officer at Rock Health, will lead this session featuring insights from industry experts: ?? Dianna Budgeon, SVP, Clinical Operations at knownwell ?? Dan Knecht, Chief Clinical Innovation Officer at CVS Caremark ?? Sloan Saunders, CEO & Co-Founder at FlyteHealth ?? Adam Wolfberg, Chief Medical Officer at Virta Health ?? Rich Yang, CEO at Biolinq This panel session will explore the future of healthcare, including how GLP-1s are reshaping obesity care, impacting healthcare delivery, and changing economic models. Expect in-depth discussions on the opportunities, trade-offs, and challenges these innovations bring to the industry. ?? Reserve your seat today: https://lnkd.in/e4ecNEat ??? See the full agenda: https://lnkd.in/e5M9jkur With 600+ global attendees, 100+ speakers, and 80+ presenting companies, BioFuture? 2024 will offer an unparalleled experience, featuring fireside chats, panels, and new #TechBio sessions. Register now to schedule one-to-one meetings and join networking receptions with global investors and pharma partners. ?? Get all the details here: https://lnkd.in/eY-xFwcv Cure. #GLP1 #ObesityCare #Biotech #Biopharma #Healthcare #LifeSciences #Innovation #DrugDevelopment #VCFunding #Partnering #BiotechLeaders #FutureOfHealthcare #DemyColton

In this podcast episode, Biolinq CEO Rich Yang reveals that he once vetoed his VC firm’s investment in the company. But something obviously changed his mind about the company’s novel approach to monitoring glucose and, hopefully, hormones and other critical elements. If you like what you hear, join us at DeviceTalks West where Yang will give a presentation about Biolinq’s unique technology. Register now at West.DeviceTalks.com and use the code DTPOD25 to save 25%. Also in the episode, MassDevice Editor Chris Newmarker shares his Newmarker’s Newsmakers of the week – Route 92, Stryker, Medtronic, Siemens Healthineers, Masimo and #urology companies. LISTEN HERE: https://lnkd.in/ewrvhSzT #GlucoseMonitoring #gluocse #hormones #DeviceTalksWeekly Tom Salemi Kayleen Brown

Our Co-founder, President and CTO Jared Tangney presented at the LSI Europe conference last week, and discussed what our team has been building at #biolinq. ???? For the past 10 years we’ve been at work to reimagine #biosensing from just below the surface of the skin and engineered a new category of #sensors that opens a world of possibilities to deliver new insights about your health. Learn more here: ???? https://www.biolinq.com/

Another impressive Demo Day for the books! We are so thankful to Qualcomm, our sponsors, our incredible presenters, and our supportive community! Without all of you, we would not be able to pull off such an amazing event. Attendees heard from seven EvoNexus graduate portfolio companies, each with interesting stories and directions for the future. At the end, the audience voted for their favorite presentation and Biolinq was crowned the winner of the 2024 EvoNexus Demo Day! Thank you again to everyone who made this a night to remember. Stay tuned for even more exciting news and events! Talk soon! ??? #medtech #EvoNexus #demoday #demoday2024 #Qualcomm #Innovation DeepWater Exploration Inc. BRELYON Fabric8Labs Housecall Pro Carlsmed Syntiant Corp. Obsidian Sensors #TechEvent #semiconductor #saas #biosensors #automotive #3dprinting #sandiego #sdinnovation

Today's #SpeakerSpotlight shines on Rich Yang, CEO of Biolinq, who is driving innovation in metabolic health. With over 20 years of experience in #medtech, Rich leads the charge in transforming how we monitor health in real-time using Biolinq's multi-analyte platform. This cutting-edge wearable technology places microsensors beneath the skin, offering continuous, precise biosensing of key health biomarkers. At DeviceTalks West 2024, Rich will share how: ? Biolinq is redefining the future of metabolic health with real-time, personalized monitoring. ? Biolinq is making healthcare more accessible, proactive, and patient-focused. ?? October 16-17, 2024 ?? Santa Clara, CA ?? Register now: west.devicetalks. com #DTWest2024 #WearableTech #PrecisionMedicine #Conference